Endo International Plc (ENDP)

6.52
NASDAQ : Health Technology
Prev Close 6.60
Day Low/High 6.51 / 6.77
52 Wk Low/High 5.92 / 18.50
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 226.18M
Market Cap 1.49B
EPS -4.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan

Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan

Endo Pharmaceutical is downgraded to underweight from neutral at JPMorgan.

Endo Reports First-Quarter 2019 Financial Results

Endo Reports First-Quarter 2019 Financial Results

DUBLIN, May 9, 2019 /PRNewswire/ -- First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile Injectables revenues increased 25 percent to $270 million compared to...

Interesting ENDP Put And Call Options For June 14th

Interesting ENDP Put And Call Options For June 14th

Investors in Endo International plc saw new options begin trading today, for the June 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new June 14th contracts and identified one put and one call contract of particular interest.

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall Of One Lot Of Mycophenolate Mofetil For Injection, USP Due To The Presence Of A Glass Fragment Observed In One Vial Of Reconstituted Product

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall Of One Lot Of Mycophenolate Mofetil For Injection, USP Due To The Presence Of A Glass Fragment Observed In One Vial Of Reconstituted Product

DUBLIN, May 1, 2019 /PRNewswire/ -- Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc.

Endo To Announce First-Quarter 2019 Financial Results

Endo To Announce First-Quarter 2019 Financial Results

DUBLIN, April 10, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2019 financial results on May 9, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a.

Endo Begins Shipment Of Authorized Generic Version Of PROVENTIL® (albuterol Sulfate) HFA Inhalation Aerosol In The United States

Endo Begins Shipment Of Authorized Generic Version Of PROVENTIL® (albuterol Sulfate) HFA Inhalation Aerosol In The United States

DUBLIN , April 5, 2019 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's PROVENTIL ® (albuterol sulfate)...

Endo International Plc Announces Early Tender Results Of Its Previously Announced Cash Tender Offers And Consent Solicitations For Up To $1.5 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

Endo International Plc Announces Early Tender Results Of Its Previously Announced Cash Tender Offers And Consent Solicitations For Up To $1.5 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

DUBLIN, March 27, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (the "Company" or "Endo")  today announced the early tender results of the previously announced cash tender offers (the "Tender Offers") made by Endo Finance LLC ("Endo...

First Week Of ENDP May 17th Options Trading

First Week Of ENDP May 17th Options Trading

Investors in Endo International plc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Leading Peer-Reviewed Dermatology Journal Features Phase 2 Data DUBLIN, March 19, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") for the...

Endo International Plc Announces An Upsizing Of Its Cash Tender Offers And Consent Solicitations

Endo International Plc Announces An Upsizing Of Its Cash Tender Offers And Consent Solicitations

DUBLIN, March 14, 2019 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) today announced an upsizing of its previously announced cash tender offers (the "Tender Offers") and consent solicitations by Endo Finance LLC ("Endo Finance"), a wholly-owned...

Endo International Plc Announces Pricing Of Private Offering Of Senior Secured Notes

Endo International Plc Announces Pricing Of Private Offering Of Senior Secured Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc.

Endo International Plc Announces Debt Refinancing Transactions, Including Cash Tender Offers And Consent Solicitations For Up To $1.0 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

Endo International Plc Announces Debt Refinancing Transactions, Including Cash Tender Offers And Consent Solicitations For Up To $1.0 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced a series of debt refinancing transactions that are intended to help manage the debt maturity profile of it and certain of its subsidiaries (collectively, the...

Endo International Plc Announces Proposed Private Offering Of Senior Secured Notes

Endo International Plc Announces Proposed Private Offering Of Senior Secured Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc.

Endo To Participate At Cowen & Company 39th Annual Healthcare Conference

Endo To Participate At Cowen & Company 39th Annual Healthcare Conference

DUBLIN, March 4, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Cowen & Company 39 th Annual Healthcare Conference in Boston, Massachusetts on Monday, March...

Endo Announces FDA Decision Not To Include Vasopressin On 503B Bulks List

Endo Announces FDA Decision Not To Include Vasopressin On 503B Bulks List

DUBLIN, March 1, 2019 /PRNewswire/ --  Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.

Endo Will Showcase Late-Breaking Phase 3 CCH Data At The 2019 American Academy Of Dermatology Annual Meeting

Endo Will Showcase Late-Breaking Phase 3 CCH Data At The 2019 American Academy Of Dermatology Annual Meeting

Endo To Present Data From Two Abstracts on Collagenase Clostridium Histolyticum DUBLIN, March 1, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it will present new data showing collagenase clostridium histolyticum (CCH)...

Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

DUBLIN, Feb. 28, 2019 /PRNewswire/ -- Fourth-quarter 2018 revenues increased 2 percent to $786 million Fourth-quarter 2018 Sterile Injectables revenues increased 32 percent to $259 million Fourth-quarter 2018 XIAFLEX ® franchise revenues increased 30...

Endo Announces Termination Of Acquisition Agreements With Somerset Therapeutics And Business Of Affiliate Wintac Limited

Endo Announces Termination Of Acquisition Agreements With Somerset Therapeutics And Business Of Affiliate Wintac Limited

DUBLIN, Feb. 27, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Endo Ventures Limited, Par Pharmaceutical, Inc.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

ENDP March 29th Options Begin Trading

ENDP March 29th Options Begin Trading

Investors in Endo International plc saw new options begin trading today, for the March 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new March 29th contracts and identified one put and one call contract of particular interest.

Endo Agrees Not To Oppose Additional Stay Of FDA Litigation Following Restoration Of Government Appropriations

Endo Agrees Not To Oppose Additional Stay Of FDA Litigation Following Restoration Of Government Appropriations

DUBLIN, Feb. 7, 2019 /PRNewswire/ --  Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.

Endo To Announce Fourth-Quarter And Full-Year 2018 Financial Results

Endo To Announce Fourth-Quarter And Full-Year 2018 Financial Results

DUBLIN, Jan. 25, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2018 financial results on February 28, 2019 and members of its senior management team will host a conference call and webcast at...

Endo Announces Anticipated Further Stay Of Compounding Litigation Due To Lapse Of Government Appropriations

Endo Announces Anticipated Further Stay Of Compounding Litigation Due To Lapse Of Government Appropriations

DUBLIN, Dec. 31, 2018 /PRNewswire/ --  Endo International plc ("Endo"; NASDAQ: ENDP) today announced that, due to the ongoing federal government shutdown, the U.

Endo To Participate At J.P. Morgan Healthcare Conference

Endo To Participate At J.P. Morgan Healthcare Conference

DUBLIN, Dec. 19, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.

Endo To Participate At Bank Of America Merrill Lynch Leveraged Finance Conference

Endo To Participate At Bank Of America Merrill Lynch Leveraged Finance Conference

DUBLIN, Nov. 28, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida on Tuesday,...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BKE, CEL, INOD, INTX, MDP Downgrades: ATTO, BPI, CPE, ENDP, NP Initiations: BGNE Read on to get TheStreet Quant Ratings' detailed report:

Endo To Participate At Piper Jaffray Global Healthcare Conference

Endo To Participate At Piper Jaffray Global Healthcare Conference

DUBLIN, Nov. 26, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Piper Jaffray Global Healthcare Conference in New York City on Tuesday, November 27, 2018 at...

First Week Of ENDP July 2019 Options Trading

First Week Of ENDP July 2019 Options Trading

Investors in Endo International plc saw new options become available this week, for the July 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D+ (Sell)